156 related articles for article (PubMed ID: 22212909)
1. Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.
Matoka DJ; Yao V; Harya DS; Gregg JL; Robinson AR; Niedernhofer LJ; Parwani AV; Maier C; Bacich DJ
Prostate; 2012 Aug; 72(11):1214-22. PubMed ID: 22212909
[TBL] [Abstract][Full Text] [Related]
2. The ERCC1 and ERCC4 (XPF) genes and gene products.
Manandhar M; Boulware KS; Wood RD
Gene; 2015 Sep; 569(2):153-61. PubMed ID: 26074087
[TBL] [Abstract][Full Text] [Related]
3. XPF-ERCC1 protects liver, kidney and blood homeostasis outside the canonical excision repair pathways.
Mulderrig L; Garaycoechea JI
PLoS Genet; 2020 Apr; 16(4):e1008555. PubMed ID: 32271760
[TBL] [Abstract][Full Text] [Related]
4. Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc1-/- mice.
Prasher JM; Lalai AS; Heijmans-Antonissen C; Ploemacher RE; Hoeijmakers JH; Touw IP; Niedernhofer LJ
EMBO J; 2005 Feb; 24(4):861-71. PubMed ID: 15692571
[TBL] [Abstract][Full Text] [Related]
5. Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.
Gregg SQ; Robinson AR; Niedernhofer LJ
DNA Repair (Amst); 2011 Jul; 10(7):781-91. PubMed ID: 21612988
[TBL] [Abstract][Full Text] [Related]
6. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
Kirschner K; Melton DW
Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
[TBL] [Abstract][Full Text] [Related]
7. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
Bergstralh DT; Sekelsky J
Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
[TBL] [Abstract][Full Text] [Related]
8. ERCC1 mutations impede DNA damage repair and cause liver and kidney dysfunction in patients.
Apelt K; White SM; Kim HS; Yeo JE; Kragten A; Wondergem AP; Rooimans MA; González-Prieto R; Wiegant WW; Lunke S; Flanagan D; Pantaleo S; Quinlan C; Hardikar W; van Attikum H; Vertegaal ACO; Wilson BT; Wolthuis RMF; Schärer OD; Luijsterburg MS
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33315086
[TBL] [Abstract][Full Text] [Related]
9. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
[TBL] [Abstract][Full Text] [Related]
10. ERCC1-XPF endonuclease facilitates DNA double-strand break repair.
Ahmad A; Robinson AR; Duensing A; van Drunen E; Beverloo HB; Weisberg DB; Hasty P; Hoeijmakers JH; Niedernhofer LJ
Mol Cell Biol; 2008 Aug; 28(16):5082-92. PubMed ID: 18541667
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW
DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741
[TBL] [Abstract][Full Text] [Related]
12. DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.
McNeil EM; Melton DW
Nucleic Acids Res; 2012 Nov; 40(20):9990-10004. PubMed ID: 22941649
[TBL] [Abstract][Full Text] [Related]
13. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
[TBL] [Abstract][Full Text] [Related]
14. Mice with skin-specific DNA repair gene (Ercc1) inactivation are hypersensitive to ultraviolet irradiation-induced skin cancer and show more rapid actinic progression.
Doig J; Anderson C; Lawrence NJ; Selfridge J; Brownstein DG; Melton DW
Oncogene; 2006 Oct; 25(47):6229-38. PubMed ID: 16682947
[TBL] [Abstract][Full Text] [Related]
15. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence.
Weeda G; Donker I; de Wit J; Morreau H; Janssens R; Vissers CJ; Nigg A; van Steeg H; Bootsma D; Hoeijmakers JH
Curr Biol; 1997 Jun; 7(6):427-39. PubMed ID: 9197240
[TBL] [Abstract][Full Text] [Related]
16. Removal of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1.
Fisher LA; Samson L; Bessho T
Chem Res Toxicol; 2011 Nov; 24(11):1876-81. PubMed ID: 22007867
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
Arora S; Kothandapani A; Tillison K; Kalman-Maltese V; Patrick SM
DNA Repair (Amst); 2010 Jul; 9(7):745-53. PubMed ID: 20418188
[TBL] [Abstract][Full Text] [Related]
18. The knock-down of ERCC1 but not of XPF causes multinucleation.
Rageul J; Frëmin C; Ezan F; Baffet G; Langouët S
DNA Repair (Amst); 2011 Sep; 10(9):978-90. PubMed ID: 21839691
[TBL] [Abstract][Full Text] [Related]
19. Mice with DNA repair gene Ercc1 deficiency in a neural crest lineage are a model for late-onset Hirschsprung disease.
Selfridge J; Song L; Brownstein DG; Melton DW
DNA Repair (Amst); 2010 Jun; 9(6):653-60. PubMed ID: 20362516
[TBL] [Abstract][Full Text] [Related]
20. A neurological phenotype in mice with DNA repair gene Ercc1 deficiency.
Lawrence NJ; Sacco JJ; Brownstein DG; Gillingwater TH; Melton DW
DNA Repair (Amst); 2008 Feb; 7(2):281-91. PubMed ID: 18221731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
